Efficacy and safety of nintedanib in Japanese patients with early-stage idiopathic pulmonary fibrosis: a study protocol for an observational study

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a fibrotic disease of unknown aetiology with a poor prognosis. Several clinical trials of nintedanib in patients with IPF have reported its inhibitory effect on reduced lung function, incidence of acute exacerbation of IPF and worsened health-rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Noriho, Hamada, Naoki, Okamoto, Masaki, Tobino, Kazunori, Ichiyasu, Hidenori, Ishii, Hiroshi, Ichikado, Kazuya, Morimoto, Shimpei, Hosogaya, Naoki, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245432/
https://www.ncbi.nlm.nih.gov/pubmed/34187824
http://dx.doi.org/10.1136/bmjopen-2020-047249